Position in ASND
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$35,269,936
+$28,066,690 QoQ
Shares Held
154,199
+356.5% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.70038716204385.ToString("F0")%
Shared 0.ToString("F0")%
None 0.29961283795614757.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$26,075,220
PutShares
114,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,850,561 across 389 Biotechnology names. ASND ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ASND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,075,220 | 114,000 | Put | Defined | 2026-05-11 | |
| 2026-03-31 | $35,269,936 | 154,199 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $7,203,246 | 33,780 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,296,311 | 31,670 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,435,346 | 31,491 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,753,264 | 24,081 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,567,269 | 18,648 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,490,042 | 16,677 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,446,990 | 10,610 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,672,090 | 11,061 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,318,065 | 10,465 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $930,312 | 9,935 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $965,594 | 10,819 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,150,683 | 10,732 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,314,117 | 10,760 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $954,946 | 9,248 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $894,367 | 9,621 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,264,817 | 61,902 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,748,389 | 57,596 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $55,155,472 | 346,041 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,481,120 | 11,259 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,053,850 | 8,177 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $559,378 | 3,354 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $448,916 | 2,909 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $585,535 | 3,959 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $676,672 | 6,009 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||